🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Hamza Anwer, Head of Research at Cure Brain Cancer Foundation shares highlights from the 2025 Australian Children’s Brain Cancer Conference (ACBCC) in Brisbane. curebraincancer.org.au/about-us/news/… #braincancer #braincancerresearch #paediatricbraincancer #acbcc

The young schoolboy who captivated a state with his dream of becoming a police officer has lost his brave battle with brain cancer. 🕊️ 🔗 Read more: bit.ly/42A2N9A #sergeansammy #sammyscully #braincancer #southaustralia

New hope for #braincancer as Telix Pharmaceuticals’s glioblastoma theranostic, TLX-101, shows promising overall survival in a phase II trial in recurrent high-grade glioma. bioworld.com/articles/719335 #biopharma #glioblastoma #radiopharmaceuticals

Ohio State Researchers Report that Targeting the Enzyme Pgm3 Shows Strong Potential in Stopping the Progression of Glioblastoma - Check the Link for More shorturl.at/qKtRL #Glioblastoma #RareDisease The Ohio State University Wexner Medical Center #BrainCancer #GBM #OrphanDrugs

curetoday.com/view/tlx101-de… via CURE Today

A new study from the Centre for Immuno-Oncology has found that depleting Treg cells can suppress tumour growth in #glioblastoma. Their findings have uncovered a possible new way to develop novel therapies for this specific type of cancer 🧠🔬 Read more 👉 ndm.ox.ac.uk/news/study-fin…

📣 Nominate excellence in #NeuroOncology! EANO is accepting #award nominations (research, mentorship, diversity, care) and #scholarship applications for #EANO2025. 🗓️ May 15, 2025 📧 [email protected] Learn more: eano.eu/eanomeetings/e…

Today marks the start of #BrainCancerAwarenessMonth—a time to shine a light on one of the most underfunded and overlooked cancers. Nearly 2,000 Australians are diagnosed each year. We’re here to fight for them. 💜 #GoGreyInMay #CureBrainCancer #BrainCancerAwareness

In honor of Brain Tumor Awareness Month, we’re excited to highlight Dr. Howard Colman, GBM AGILE Regional PI, United States, Arm Selection Committee Member, VT10021 arm Co-PI, Professor, Huntsman Cancer Institute and Department of Neurosurgery, University of Utah. Dr. Colman discusses

We are thrilled to announce that AstraZeneca’s AZD1390 is now enrolling in GBM AGILE! AstraZeneca’s AZD1390 is entering the GBM AGILE, the world’s first global adaptive platform trial for patients with #glioblastoma, as the 7th investigational arm. AZD1390 will be evaluated for

This #BrainCancerAwarenessMonth, we're spotlighting the Australian research institutions making progress in brain cancer. #CureBrainCancer #BrainCancerResearch #BrainCancerAwareness Childrens Cancer Institute WEHI (Walter and Eliza Hall Institute) Chris O’Brien Lifehouse Centre for Cancer Biology QIMR Berghofer azhar MarkHughesFoundation

Applications for CBCF's Early Career Fellowship open Monday 26 May. This Fellowship provides stability and support for early-career researchers to drive the breakthroughs that could shift the trajectory of brain cancer. Find out more here: curebraincancer.org.au/research/for-r…

Applications are now open for Cure Brain Cancer Foundation’s Early Career Fellowship. We’re calling on emerging researchers with bold ideas and a drive to make meaningful change in the future of brain cancer research. Apply here: curebraincancer.org.au/research/for-r… #BrainCancerResearch

We are excited to announce that Cure Brain Cancer Cure Brain Cancer Foundation will be our GOLD sponsor for the 2025 ABCARA symposium on the Gold Coast on September 17th. Registrations and Abstract submission open shortly.

A recent pair of studies published in Nature Genetics and co-led by Yale School of Medicine's Roel Verhaak & Kevin Johnson sheds light on glioblastoma 👁️, the heterogeneity of its cellular composition, and how these cells evolve with time 🧬🔬 #BrainCancer Yale Cancer Center medicine.yale.edu/news-article/s…

Announcing our international plenary speaker for ABCARA 2025, Dr Adam Sonabend. We will be opening registration shortly - and this will be a must attend symposium. Proudly supported by MarkHughesFoundation and Cure Brain Cancer

Brain cancer strikes with terrifying speed, leaving people like Leanne reeling at how little time they have left. Please, donate to support life-saving brain cancer research like this to help secure more time for families facing brain cancer: give.curebraincancer.org.au

Every breakthrough starts with a discovery. These two game-changing findings are helping fast-track brain cancer research and reimagine what’s possible for patients. #BrainCancerBreakthroughs #CureBrainCancer #MedicalResearch #AIInMedicine #ForBrainCancer #HopeThroughScience

Announcing our next plenary speaker for the ABCARA 2025 Symposium, Dr Thomas Park from New Zealand. The program is building - head to abcara.com to register and submit your Abstract. Proudly sponsored by MarkHughesFoundation and Cure Brain Cancer

Come hear our distinguished international speakers Prof. Katy Peters, Prof. Rakesh Jalali, A/Prof. Adam Sonabend and A/Prof. Karin Piil present at the #COGNO25 ASM in September. Want to learn more about our speakers and register? Visit mers.cventevents.com/event/COGNO-AS… #BrainCancer